Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
Read Article
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Read Article
Providence and Compassus announce joint venture for home-based care services
Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.
Read Article
Leading Health Systems Form New Organization to Transform the Development and Delivery of Health Care Solutions
Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have announced the formation of Longitude Health.
Read Article
Providence researchers identify factors that may influence MCED test adoption for communities facing health care access barriers
Year-long study, published in Health Affairs Scholar, prompts need for multi-level intervention to increase adoption rates, combat cancer inequities
Read Article
New data: Average primary care physician faces meeting 57 different quality measures each year
A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention
Read Article
New Data: MedPearl clinical decision platform improves specialty referrals, boosts productivity, and reduces clinician time spent in the EMR
Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.
Read Article
Providence reports Q2 2024 results
Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.
Read Article
Can these new studies offer hope for people with lung and head and neck cancers?
A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.
Read Article
Erik Wexler to serve as the next president and CEO for Providence
The Providence St. Joseph Health Board of Directors announced that Providence Chief Operating Officer Erik Wexler has been named the health system’s next president and chief executive officer.
Read Article
Furthering the Mission: Providence extends spiritual health services to caregivers and families through virtual offerings
Supporting people in times of need, remote capabilities have enabled Providence chaplains to care for over 1,000 people since 2022.
Read Article
Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection
Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.
Read Article
Providence provides $2.1B in community benefit, including high-impact investments, in 2023
Investments focus on addressing social determinants of health and ensuring continued access to vital care for those in need
Read Article
Providence caregivers can build connection and awareness of community health needs through service
Network members focus on helping caregivers address community health needs through service, advocacy, and giving.
Read Article
Catholic Health Association of the United States names Orest Holubec chair-elect; Anna Newsom also joining board
CHA has named Providence Chief Communication Officer Orest Holubec as vice chairperson/chairperson-elect of the CHA Board of Trustees, while Chief Legal Officer Anna Newsom was elected to the Board.
Read Article
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
Read Article
Providence researchers conducted over 2400 studies in 2023, according to new report
The 2023 Providence Research Network annual report, released on Clinical Trials Day 2024, highlights the breadth and impact of research at Providence.
Read Article
Providence reports Q1 2024 results
With a continued focus on strategies for recovery and renewal, Providence reported a positive first quarter.
Read Article
Providence president and CEO Rod Hochman, M.D., announces retirement
After 45 years in health care, including 17 with the Providence family of organizations, Rod Hochman, M.D., announced that he will retire as president and CEO of Providence at the end of 2024.
Read Article
30 Providence hospitals land national recognition for environmental stewardship work
Providence has been presented with 55 Practice Greenhealth Environmental Excellent Awards in recognition of exceptional environmental stewardship across the organization.
Read Article